Combining Gene Editing and iPS to Study and Treat Monogenic Autoinflammatory Diseases | MicrobiomeTrials← Back to trialsNCT07889947
Combining Gene Editing and iPS to Study and Treat Monogenic Autoinflammatory Diseases
RecruitingOBSERVATIONAL
Trial Details
Start: 2026-03-25Est. Completion: 2026-12-31
Enrollment target: 6 participants Locations- Presidio Azienda Universitaria Ospedaliera Consorziale - Policlinico Bari, Bari, Italy
- IRCCS Istituto Giannina Gaslini, Genova, Italy
Other microbiome trials you might be interested in
Trisomy 8 MosaicismTrisomy 8 Associated Autoinflammatory DiseaseMucosal Ulcerations
Background:
Trisomy 8 mosaicism is a genetic disorder that can increase inflammation in the body. Symptoms include feve…
Bethesda, United StatesEst. completion May 1, 2056
Autoinflammatory DiseaseJuvenile Dermatomyositis
Purpose:
The purpose of this protocol is 1. To comprehensively evaluate patients with autoinflammatory diseases clinica…
Bethesda, United States